TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results [Yahoo! Finance]
TG Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
TG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "buy" rating re-affirmed by analysts at LADENBURG THALM/SH SH. They now have a $39.00 price target on the stock.
TG Therapeutics, Inc. (NASDAQ: TGTX) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $25.00 price target on the stock.